Table 1 Characteristics of infants and their mothers.
From: The impact of CREBRF rs373863828 Pacific-variant on infant body composition
Characteristics | Total | N | Infant CREBRF rs373863828 genotype | P | |||
---|---|---|---|---|---|---|---|
A/G or A/A* | N | G/G | N | ||||
Maternal characteristics | |||||||
rs373863828 genotype | 67 | 18 | 49 | 0.01 | |||
A/A | 2 (3.0%) | 2 (11.1%) | 0 (0.0%) | ||||
A/G | 12 (17.9%) | 6 (33.3%) | 6 (12.2%) | ||||
G/G | 48 (71.6%) | 9 (50.0%) | 39 (79.6%) | ||||
Unknown | 5 (7.5%) | 1 (5.6%) | 4 (8.2%) | ||||
Age, years | 29.0 (5.7) | 67 | 30.1 (5.9) | 18 | 28.5 (5.6) | 49 | 0.30 |
Nulliparous | 14 (20.9%) | 67 | 3 (16.7%) | 18 | 11 (22.5%) | 49 | 0.74 |
Smoking in pregnancy | 19 (28.4%) | 67 | 6 (33.3%) | 18 | 13 (26.5%) | 49 | 0.76 |
BMI, kg/m2 | 39.8 (6.7) | 67 | 41.1 (5.9) | 18 | 39.4 (7.0) | 49 | 0.37 |
30.0 to 34.9 | 13 (19.4%) | 67 | 3 (16.7%) | 18 | 10 (20.4%) | 49 | |
≥ 35.0 | 54 (80.6%) | 67 | 15 (83.3%) | 18 | 39 (79.6%) | 49 | |
GDM (IADPSG) | 15 (26.3%) | 57 | 2 (11.8%) | 17 | 13 (32.5%) | 40 | 0.19 |
OGTT plasma glucose concentration at 24–28 weeks, mmol/L | |||||||
Fasting | 4.7 (0.4) | 57 | 4.6 (0.4) | 17 | 4.7 (0.5) | 40 | 0.30 |
1 h | 8.0 (1.5) | 41 | 8.1 (1.4) | 12 | 8.0 (1.6) | 29 | 0.79 |
2 h | 6.2 (1.2) | 57 | 6.0 (1.7) | 17 | 6.2 (1.0) | 40 | 0.65 |
Socioeconomic deprivation# | 57 (85.1%) | 67 | 16 (88.9%) | 18 | 41 (83.7%) | 49 | 0.72 |
HUMBA trial interventions | |||||||
Dietary intervention | 35 (52.2%) | 67 | 8 (44.4%) | 18 | 27 (55.1%) | 49 | 0.58 |
Probiotic capsule | 31 (46.3%) | 67 | 8 (44.4%) | 18 | 23 (46.9%) | 49 | 1.00 |
Infant characteristics | |||||||
Ethnicity | 67 | 18 | 49 | 1.00 | |||
Māori | 25 (37.3%) | 7 (38.9%) | 18 (36.7%) | ||||
Pacific | 42 (62.7%) | 11 (61.1%) | 31 (63.3%) | ||||
Sex, female | 31 (46.3%) | 67 | 7 (38.9%) | 18 | 24 (49.0%) | 49 | 0.58 |
Caesarean birth | 18 (26.9%) | 67 | 7 (38.9%) | 18 | 11 (22.4%) | 49 | 0.22 |
Gestation length, weeks | 39.7 (1.4) | 67 | 39.5 (1.6) | 18 | 39.7 (1.3) | 49 | 0.67 |
< 37 weeks | 2 (3.0%) | 67 | 1 (5.6%) | 18 | 1 (2.0%) | 49 | |
≥ 37 weeks | 65 (97.0%) | 67 | 17 (94.4%) | 18 | 48 (98.0%) | 49 |